Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET

COVETRUS, INC.

(CVET)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Covetrus: 3Q Earnings Snapshot

11/10/2020 | 04:41pm EST

PORTLAND, Maine (AP) _ Covetrus Inc. (CVET) on Tuesday reported a loss of $35 million in its third quarter.

The Portland, Maine-based company said it had a loss of 33 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, came to 23 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 16 cents per share.

The animal health technology and services company posted revenue of $1.13 billion in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $1.04 billion.

Covetrus shares have risen 97% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $26.01, more than doubling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CVET at https://www.zacks.com/ap/CVET

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about COVETRUS, INC.
01/13COVETRUS, INC. : Results of Operations and Financial Condition, Regulation FD Di..
AQ
01/06COVETRUS : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
01/04COVETRUS : Presidio Announces Appointment of Christine Komola as New CFO
AQ
2020COVETRUS : Completes Separation from Former Parent Company
BU
2020COVETRUS, INC. : Submission of Matters to a Vote of Security Holders, Regulation..
AQ
2020Credit Suisse Adjusts Price Target for Covetrus to $20 From $17, Maintains Ne..
MT
2020COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020Covetrus Narrows Q3 Loss Amid Higher Revenue, Ups Full Year Earnings Guidance
MT
2020COVETRUS : 3Q Earnings Snapshot
AQ
2020COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
More news
Financials (USD)
Sales 2020 4 273 M - -
Net income 2020 -23,0 M - -
Net Debt 2020 674 M - -
P/E ratio 2020 -154x
Yield 2020 -
Capitalization 4 703 M 4 703 M -
EV / Sales 2020 1,26x
EV / Sales 2021 1,17x
Nbr of Employees 5 300
Free-Float 72,5%
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 30,00 $
Last Close Price 36,88 $
Spread / Highest target -5,10%
Spread / Average Target -18,7%
Spread / Lowest Target -34,9%
EPS Revisions
Managers and Directors
NameTitle
Benjamin C. Wolin President, Chief Executive Officer & Director
Philip A. Laskaway Chairman
Matthew J. Foulston Chief Financial Officer
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.28.32%4 703
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.28%50 041
ALIGN TECHNOLOGY, INC.6.15%44 726